Sources

8 Total Sources

Retatrutide Cuts HbA1c by 1.9 Points and Weight by 15.3% in Phase 3 Diabetes Trial

Left50%

Center50%

The Guardian5h ago

Retatrutide Triple-Action Jab Shows Significant Blood Sugar, Weight Reduction in Type 2 Diabetes

Yahoo! Voices5h ago

Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits

StockTitan5h ago

Eli Lilly retatrutide cuts weight 28.3% in Phase 3 | LLY Stock News

MD Magazine5h ago

TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo | HCPLive

Instagram5h ago

Full Retatrutide data just presented at the ADA conference to a packed room. Just a refresher, it is a GLP-1/GIP/Glucagon agonist. It hits all three receptors as opposed to semaglutide which hits

Novo Nordisk's investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes--presented at ADA 2026 : r/NovoNordisk_Stock

ResearchGate5h ago

Retatrutide's mechanisms of action. | Download Scientific Diagram

revivalclinicbangkok.com5h ago

Retatrutide | Revival Clinic